Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy.

Ezquer ME, Ezquer FE, Arango-Rodríguez ML, Conget PA.

Biol Res. 2012;45(3):289-96. doi: 10.4067/S0716-97602012000300010. Review.

2.

Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.

Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA.

Biol Blood Marrow Transplant. 2008 Jun;14(6):631-40. doi: 10.1016/j.bbmt.2008.01.006. Epub 2008 Apr 14.

3.

Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.

Herbach N, Schairer I, Blutke A, Kautz S, Siebert A, Göke B, Wolf E, Wanke R.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F819-29. doi: 10.1152/ajprenal.90665.2008. Epub 2009 Feb 11.

4.

Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?

Ezquer F, Ezquer M, Arango-Rodriguez M, Conget P.

Acta Ophthalmol. 2014 Mar;92(2):e86-95. doi: 10.1111/aos.12113. Epub 2013 Jun 15. Review.

5.

Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.

Ezquer F, Ezquer M, Simon V, Pardo F, Yañez A, Carpio D, Conget P.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1354-65. doi: 10.1016/j.bbmt.2009.07.022.

6.

Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.

Steinke JM, Mauer M; International Diabetic Nephropathy Study Group..

Pediatr Endocrinol Rev. 2008 Aug;5 Suppl 4:958-63. Review.

PMID:
18806710
7.

Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.

Wang S, Li Y, Zhao J, Zhang J, Huang Y.

Biol Blood Marrow Transplant. 2013 Apr;19(4):538-46. doi: 10.1016/j.bbmt.2013.01.001. Epub 2013 Jan 4.

8.

Bone-marrow mesenchymal stem cell transplantation to treat diabetic nephropathy in tree shrews.

Pan XH, Yang XY, Yao X, Sun XM, Zhu L, Wang JX, Pang RQ, Cai XM, Dai JJ, Ruan GP.

Cell Biochem Funct. 2014 Jul;32(5):453-63. doi: 10.1002/cbf.3037. Epub 2014 May 28.

PMID:
24867093
9.

Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus.

Ezquer F, Giraud-Billoud M, Carpio D, Cabezas F, Conget P, Ezquer M.

Biomed Res Int. 2015;2015:164703. doi: 10.1155/2015/164703. Epub 2015 Jun 8.

10.

Kidney-targeted transplantation of mesenchymal stem cells by ultrasound-targeted microbubble destruction promotes kidney repair in diabetic nephropathy rats.

Zhang Y, Ye C, Wang G, Gao Y, Tan K, Zhuo Z, Liu Z, Xia H, Yang D, Li P.

Biomed Res Int. 2013;2013:526367. doi: 10.1155/2013/526367. Epub 2013 May 27.

11.

Diabetic nephropathy.

Ritz E.

Saudi J Kidney Dis Transpl. 2006 Dec;17(4):481-90.

12.
13.

Pathology of human diabetic nephropathy.

Najafian B, Alpers CE, Fogo AB.

Contrib Nephrol. 2011;170:36-47. doi: 10.1159/000324942. Epub 2011 Jun 9. Review.

PMID:
21659756
14.

Progression of diabetic nephropathy. Insights from cell culture studies and animal models.

Phillips A, Janssen U, Floege J.

Kidney Blood Press Res. 1999;22(1-2):81-97. Review.

15.

Temporal profile of diabetic nephropathy pathologic changes.

Ponchiardi C, Mauer M, Najafian B.

Curr Diab Rep. 2013 Aug;13(4):592-9. doi: 10.1007/s11892-013-0395-7. Review.

PMID:
23712652
16.

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.

Ziyadeh FN, Wolf G.

Curr Diabetes Rev. 2008 Feb;4(1):39-45. Review.

PMID:
18220694
17.

Gene therapy, a targeted treatment for diabetic nephropathy.

Lin X, Tao L, Tang D.

Curr Med Chem. 2013;20(30):3774-84. Review.

PMID:
23895680
18.

Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?

Balakumar P, Kadian S, Mahadevan N.

Pharmacol Res. 2012 Apr;65(4):430-6. doi: 10.1016/j.phrs.2012.01.004. Epub 2012 Jan 21. Review.

PMID:
22285932
19.

Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.

Lv SS, Liu G, Wang JP, Wang WW, Cheng J, Sun AL, Liu HY, Nie HB, Su MR, Guan GJ.

Int Immunopharmacol. 2013 Oct;17(2):275-82. doi: 10.1016/j.intimp.2013.05.031. Epub 2013 Jun 19.

PMID:
23791972
20.

Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.

Shahni R, Gnudi L, King A, Jones P, Malik AN.

Diabetologia. 2012 Mar;55(3):825-34. doi: 10.1007/s00125-011-2373-4. Epub 2011 Nov 18.

PMID:
22095236

Supplemental Content

Support Center